Pages that link to "Q50688402"

The following pages link to Early treatment cost in epilepsy and how it varies with seizure type and frequency (Q50688402):

Displaying 24 items.

• Bridging the Gap between Evidence and Practice for Adults with Medically Refractory Temporal Lobe Epilepsy: Is a Change in Funding Policy Needed to Stimulate a Shift in Practice? (Q26771796) (← links)
• Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples (Q26774170) (← links)
• The direct cost of epilepsy in the United States: A systematic review of estimates (Q26799129) (← links)
• The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximation. (Q30775597) (← links)
• Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides (Q33640451) (← links)
• Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review (Q34007364) (← links)
• Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels. (Q35706539) (← links)
• Health care charges for youth with newly diagnosed epilepsy (Q35966442) (← links)
• Racial/ethnic disparities in the treatment of epilepsy: what do we know? What do we need to know? (Q36535382) (← links)
• Cross-country measures for monitoring epilepsy care (Q36744161) (← links)
• Childhood febrile seizures: overview and implications (Q36811150) (← links)
• Economic aspects of epilepsy and antiepileptic treatment: a review of the literature (Q37609418) (← links)
• Characteristics of people with epilepsy who attend emergency departments: prospective study of metropolitan hospital attendees (Q40047788) (← links)
• Clinical and economic burden of breakthrough seizures (Q40644481) (← links)
• A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy (Q41691810) (← links)
• Diagnoses, procedures, drug utilization, comorbidities, and cost of health care for people with epilepsy in 2012. (Q41741674) (← links)
• Quality of Life Changes and Health Care Charges Among Youth With Epilepsy (Q41983099) (← links)
• Economic impact of epilepsy and the cost of nonadherence to antiepileptic drugs in older Medicare beneficiaries (Q50055675) (← links)
• Economic burden of epilepsy among the privately insured in the US. (Q51148198) (← links)
• The direct costs of epilepsy in Russia. A prospective cost-of-illness study from a single center in Moscow (Q51322217) (← links)
• Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). (Q53905376) (← links)
• The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy (Q80092516) (← links)
• Medical and employment-related costs of epilepsy in the USA (Q82875394) (← links)
• Health plan paid cost of epilepsy in 2009 in the U.S. (Q85351273) (← links)